NR1H4 and liver disorder: Moreover, FGF19 treatment protected mice from CBDL-induced liver injury, whereas selective intestinal FXR overexpression decreased liver injury in the genetic Mdr2 knockout mouse model of cholestasis, confirming the importance of intestinal FXR for liver disease.91